Novel PDGFRB fusions in childhood B- and T-acute lymphoblastic leukemia

Leukemia. 2017 Sep;31(9):1989-1992. doi: 10.1038/leu.2017.161. Epub 2017 May 29.

Authors

A M Heilmann¹, A B Schrock¹, J He¹, M Nahas¹, K Curran², N Shukla², S Cramer³, L Draper⁴, A Verma⁴, R Erlich¹, J Ross^{1

5}, P Stephens¹, V A Miller¹, S M Ali¹, J-A Verglio¹, M S Tallman², T I Mughal^{1

6}

Affiliations

¹ Foundation Medicine Inc., Cambridge, MA, USA.
² Memorial Sloane Kettering Cancer Center, New York, NY, USA.
³ University of Alabama, Birmingham, MS, USA.
⁴ University of Utah, Salt Lake City, UT, USA.
⁵ Albany College of Medicine, Albany, NY, USA.
⁶ Tufts University Medical Center, Boston, MA, USA.

PMID: 28552906
DOI: 10.1038/leu.2017.161

No abstract available

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Child
Child, Preschool
Female
Hematopoietic Stem Cell Transplantation
Humans
Male
Oncogene Proteins, Fusion / genetics*
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / genetics*
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / therapy
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / genetics*
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / therapy
Receptor, Platelet-Derived Growth Factor beta / genetics*

Substances

Oncogene Proteins, Fusion
Receptor, Platelet-Derived Growth Factor beta